Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Comprehensive urine drug profiles - Insights
Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.
Chain of custody drug testing - Insights
Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.
Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
Next-generation sequencing - Insights
Browse our comprehensive next-generation sequencing test menu for patients who have bleeding and thrombosis disorders.
Minimal residual disease - Insights
Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.